357 results match your criteria Dyshidrotic Eczema


Severe Dyshidrotic Eczema in Skin of Color.

J Cutan Med Surg 2022 May 22:12034754221101542. Epub 2022 May 22.

Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article and Full-Text PDF

Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.

JAMA Dermatol 2022 Jun;158(6):650-660

Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.

Importance: Palmoplantar pustulosis (PPP) has been reported to be accompanied by systemic conditions. However, the risks of comorbidities in patients with PPP have rarely been evaluated.

Objective: To assess the risks of comorbidities in patients with PPP compared with patients with psoriasis vulgaris or pompholyx. Read More

View Article and Full-Text PDF

Pompholyx as a side effect of intravenous immunoglobulin (IVIg).

BMJ Case Rep 2022 Mar 30;15(3). Epub 2022 Mar 30.

Dermatology, Beaumont Hospital, Dublin, Ireland.

Intravenous immunoglobulin (IVIg) is increasingly used across multiple specialties for the treatment of inflammatory and autoimmune diseases. Cutaneous reactions to IVIg are generally minor. Pompholyx is a common eruption of small vesicles on the palms, soles, and/or lateral aspects of the fingers. Read More

View Article and Full-Text PDF

Low Dose Oral Alitretinoin With Narrowband Ultraviolet B Therapy for Chronic Hand Dermatitis.

J Cutan Med Surg 2022 May-Jun;26(3):256-261. Epub 2022 Jan 23.

152997 Division of Dermatology, Faculty of Health Sciences, McMaster University, ON, Canada.

Background: Chronic hand dermatitis (CHD) is difficult to treat and has high individual and societal burdens. Phototherapy and oral alitretinoin are safe monotherapies for CHD, but their combination has not been assessed.

Objective: To assess the effectiveness and safety of low dose oral alitretinoin combined with phototherapy versus high dose oral alitretinoin for CHD refractory to topical corticosteroids. Read More

View Article and Full-Text PDF

Characterizing demographics and cost of care for dyshidrotic eczema.

Contact Dermatitis 2022 Feb 5;86(2):107-112. Epub 2021 Dec 5.

Department of Dermatology, Penn State Health Hershey Medical Center, Hershey, Pennsylvania, USA.

Background: Dyshidrotic eczema (DE) is a common form of eczema affecting the hands, feet, or both areas. To date, there has been little research examining demographics and cost burden associated with this disease.

Objective: This study seeks to characterize the demographics of patients affected and the direct costs of care associated with DE. Read More

View Article and Full-Text PDF
February 2022

Unilateral Pompholyx in a Patient of Anterior Horn Disease: An Unusual Presentation.

Dermatol Pract Concept 2021 Jul 8;11(3):e2021047. Epub 2021 Jul 8.

Department of Pathology, AIIMS, Bhubaneswar, India.

View Article and Full-Text PDF

Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series.

JAAD Case Rep 2021 Jul 20;13:46-48. Epub 2021 Apr 20.

Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia.

View Article and Full-Text PDF

Herpetic whitlow masquerading as pompholyx in a healthcare worker: revisiting the entity in today's era.

Int J Dermatol 2021 Sep 1;60(9):1168-1169. Epub 2021 Mar 1.

Department of Dermatology, Lady Hardinge Medical College, New Delhi, India.

View Article and Full-Text PDF
September 2021

[Palmoplantar dermatoses in children].

Hautarzt 2021 Mar 12;72(3):215-224. Epub 2021 Feb 12.

Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München LMU, Frauenlobstr. 9-11, 80337, München, Deutschland.

Dermatoses of the hands and feet cover a wide range of skin diseases that can occur in children and adolescents and are a frequent question in dermatological practice. Our synopsis of the most important differential diagnoses and their treatment is intended to provide better orientation for daily practice. A precise and detailed history is essential to establish a diagnosis, followed by clinical examination and specific examination methods. Read More

View Article and Full-Text PDF

Factors associated with acute and recurrent erysipelas in a young population: a retrospective of 147 cases.

Tunis Med 2021 Aout;99(8):886-889

Background: erysipelas is a common infection of the superficial layer of the skin, predominantly caused by groups A β-hemolytic streptococci. It is an acute infection of the skin and frequently affects the legs. It is common in the elderly and favoured by the associated comorbidities. Read More

View Article and Full-Text PDF

Dyshidrotic Eczema: A Common Cause of Palmar Dermatitis.

Cureus 2020 Oct 7;12(10):e10839. Epub 2020 Oct 7.

Internal Medicine, University of Connecticut School of Medicine, Farmington, USA.

Dyshidrotic eczema (DE) or acute palmoplantar eczema is a common cause of hand and foot dermatitis in adults. It is a recurrent vesicular eruption affecting the soles, palms, or both. It is very pruriginous and generally appears suddenly. Read More

View Article and Full-Text PDF
October 2020

Ayurvedic visha hara (antitoxic) chikitsa in recurrent dyshidrotic eczema skin disease: A case report.

J Ayurveda Integr Med 2021 Jan-Mar;12(1):156-160. Epub 2020 Aug 27.

Department of Agada Tantra Evumvyavhara Ayurveda, Sushrutha Ayurvedic Medical College & Hospital, Bengaluru, karnataka, 560105, India.

Dyshidrotic eczema is a chronic, enigmatic condition that usually affects the hands and feet that probably accounts for about 5%-20% of hand eczemas. In Ayurveda various skin manifestation are mentioned under different chapter & context like kushtha, visarpa, kshudra kushtha, vidradi, krimi roga, keeta visha (insect bite), Garavisha &Dooshi visha (latent toxicity).Visphota variety of kushtha is characterized by pustules which are either white or reddish in appearance. Read More

View Article and Full-Text PDF

Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.

Dermatol Ther 2020 11 3;33(6):e14147. Epub 2020 Sep 3.

Department of Dermatology, Medical Faculty, Istanbul Medeniyet University, Göztepe Research and Training Hospital, Istanbul, Turkey.

Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of inflammatory and autoimmune diseases. Although skin reactions to IVIg therapy are usually minor, rare, and not life-threatening, dermatologists need to recognize the nature of these adverse reactions. We describe a 33-year-old man suffering from demyelinating polyneuropathy who developed dyshidrotic eczema on the palms and flaky grayish-white scales on an erythematous base on his face after the administration of IVIg. Read More

View Article and Full-Text PDF
November 2020

Secukinumab-induced pompholyx in a psoriasis patient.

Authors:
Gerhard Eichhoff

Dermatol Online J 2020 Apr 15;26(4). Epub 2020 Apr 15.

Dermatology Service Capital and Coast District Health Board, Wellington.

With a prevalence of up to 20%, eczematous lesions are the most common skin adverse events of tumor necrosis factor alpha inhibitors. Eczematous lesions triggered by more modern biologics such as the IL17A antagonist secukinumab have been rarely reported. Herein, a case of secukinumab-induced pompholyx in a psoriasis patient is presented. Read More

View Article and Full-Text PDF

Successful treatment of dyshidrotic palmoplantar eczema with ultraviolet A1 light-emitting diodes.

J Dermatol 2020 Aug 22;47(8):922-923. Epub 2020 May 22.

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article and Full-Text PDF

Pyogenic Flexor Tenosynovitis as a Rare Complication of Dyshidrotic Eczema.

Clin Pract Cases Emerg Med 2020 May 27;4(2):174-177. Epub 2020 Mar 27.

Mount Sinai Medical Center, Department of Emergency Medicine, Miami Beach, Florida.

Introduction: Pyogenic flexor tenosynovitis is an unusual complication of dyshidrotic eczema. The diagnosis has traditionally been made by Kanavel's signs. Point-of-care ultrasound can be a useful adjunct in the diagnosis of this surgical emergency. Read More

View Article and Full-Text PDF

Successful treatment of recalcitrant dyshidrotic eczema with oxybutynin.

Int J Dermatol 2020 Aug 9;59(8):1010-1012. Epub 2020 May 9.

Dermatology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

View Article and Full-Text PDF

Botulinum toxin type A in chronic non-dyshidrotic palmar eczema: A side-by-side comparative study.

J Dermatol 2020 Jun 14;47(6):601-608. Epub 2020 Apr 14.

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

New indications are being reported for intradermal botulinum toxin type A (BTX-A) owing to its anti-inflammatory and antipruritic actions. Its successful use for dyshidrotic hand eczema and lichen simplex has been reported in a few cases, while its utility in dry palmar eczema not associated with hyperhidrosis has not yet been investigated. The aim of this study was the assessment of the additive efficacy and tolerability of BTX-A in chronic dry palmar eczema. Read More

View Article and Full-Text PDF

as an Unusual Agent Causing Palmoplantar Eczema: An Emerging Pathogen.

Eur J Case Rep Intern Med 2020 10;7(2):001458. Epub 2020 Feb 10.

Dermatology Department, University Hospital of Heraklion, Crete, Greece.

Introduction: , described as a new species over 20 years ago, has been isolated mainly from the external ear canal and middle ear fluid. Here, we report the first case of palmoplantar eczema related to

Case Presentation: Here, we report the first case of palmoplantar eczema in a 74-year-old female related to

Conclusions: The question as to whether is a potential pathogen in cases of dyshidrotic eczema is still open, but this could be better elucidated if corynebacteria were speciated more often.

Learning Points: The coryneform bacteria and auris were recently detected for the first time in the middle ear of patients with acute otitis media and chronic otitis media. Read More

View Article and Full-Text PDF
February 2020

Dyshidrotic eczema in two patients on secukinumab for plaque psoriasis: A case report.

SAGE Open Med Case Rep 2020 10;8:2050313X20904561. Epub 2020 Feb 10.

Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada.

Secukinumab was the first fully human anti-interleukin-17a monoclonal antibody and successfully treated moderate-severe psoriasis. These new, targeted, medications are becoming more ubiquitous, but long-term side effects are not fully known. Post-market surveillance is crucial to identify delayed adverse events, analogous to the paradoxical development of pustular psoriasis in a subset of patients treated with the anti-tumor necrosis factor-alpha class drugs. Read More

View Article and Full-Text PDF
February 2020

Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients.

J Am Acad Dermatol 2020 05 8;82(5):1251-1252. Epub 2020 Jan 8.

Department of Dermatology, University of Connecticut, Farmington, Connecticut. Electronic address:

View Article and Full-Text PDF

Spongiform pemphigoid: A case series of an uncommon histopathologic pattern.

J Cutan Pathol 2020 Apr 23;47(4):339-345. Epub 2019 Dec 23.

Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.

Introduction: Bullous pemphigoid is an autoimmune bullous disease characterized by subepidermal separation. We encountered cases of bullous pemphigoid confirmed by direct immunofluorescence study but demonstrating spongiotic dermatitis without subepidermal clefting. Many of them occurred in volar sites, mimicking dyshidrotic dermatitis. Read More

View Article and Full-Text PDF

Trend of relevant contact allergens of the feet in Spain over a period of 10 years.

Contact Dermatitis 2020 Apr 28;82(4):211-217. Epub 2019 Nov 28.

Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain.

Introduction: Allergic contact dermatitis (ACD) of the feet accounts for approximately 10% of all patch tested patients.

Objective: To study the clinical profile of patients with feet dermatitis and relevant contact allergens in Spain over a 10-year period.

Methods: Retrospective observational study of patients with suspected ACD from the GEIDAC (Spanish Research Group on Contact Dermatitis and Cutaneous Allergy) baseline series from eight hospitals in Spain between 2004 and 2014. Read More

View Article and Full-Text PDF

Successful treatment of recalcitrant dyshidrotic eczema with dupilumab in a child.

J Dtsch Dermatol Ges 2019 11 14;17(11):1165-1167. Epub 2019 Oct 14.

Department of Dermatology and Allergy Biederstein, University hospital of the Technical University Munich (TUM), Munich, Germany.

View Article and Full-Text PDF
November 2019

Pompholyx vesicles contain small clusters of cells with high levels of hyaluronate resembling the pustulovesicles of palmoplantar pustulosis.

Br J Dermatol 2019 12 9;181(6):1325-1327. Epub 2019 Oct 9.

Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.

View Article and Full-Text PDF
December 2019

Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect.

Clin Cosmet Investig Dermatol 2019 10;12:223-228. Epub 2019 Apr 10.

Department of Pharmacology, Faculty of Medicine, Udayana University, Bali, Indonesia.

: Botulinum toxin (Botox) consists of 7 types of neurotoxins; however, only toxins A and B are used clinically. Botox A is used for several disorders in the field of medicine, particularly in dermatology, for cosmetic purposes. It is produced by the bacterium and can be used as a treatment to reduce the appearance of wrinkles in the upper areas of the face, elevate the eyebrows and treat problems such as hyperhidrosis, lichen simplex, pompholyx (dyshidrotic eczema) and acne vulgaris. Read More

View Article and Full-Text PDF

Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx.

J Dermatol 2019 May 28;46(5):399-408. Epub 2019 Mar 28.

Department of Dermatology, Ehime University Graduate School of Medicine, Toon, Japan.

Palmoplantar pustulosis (PPP) and pompholyx are both chronic and relapsing diseases occurring on the palms and soles. Although these two diseases have been considered completely different from each other, it is sometimes very difficult even for dermatologists to differentiate them from each other because of their similarities in clinical presentation. In this study, we aimed to analyze the histopathological features of PPP and pompholyx and find out "clues" to differentiate between PPP and pompholyx by their histopathological features. Read More

View Article and Full-Text PDF

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.

BMJ Case Rep 2019 Mar 21;12(3). Epub 2019 Mar 21.

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

View Article and Full-Text PDF

A Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab

J Drugs Dermatol 2019 Feb;18(2):211-212

A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years that impaired her ability to walk. Read More

View Article and Full-Text PDF
February 2019